Equity Transactions (Details Narrative) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
Aug. 14, 2019 |
Apr. 30, 2019 |
Apr. 09, 2019 |
Apr. 04, 2019 |
Apr. 30, 2019 |
Sep. 30, 2019 |
Sep. 30, 2018 |
Sep. 30, 2019 |
Sep. 30, 2018 |
Dec. 31, 2018 |
|
| Number of shares issued | 1,196,000 | |||||||||
| Warrant to purchase of common stock | 108,196 | 108,196 | ||||||||
| Value of shares issued for acquisition | $ 7,820,000 | |||||||||
| Number of common stock shares issued for service, value | $ 202,000 | $ (1,080,000) | $ 930,000 | $ 1,547,000 | ||||||
| Number of stock options granted | 735,667 | |||||||||
| Debt conversion amount | 788,000 | 3,066,000 | ||||||||
| Stock options intrinsic value | $ 2,660,000 | |||||||||
| Exercise price of common stock granted | $ 3.97 | |||||||||
| Fair value of warrants | $ 215,000 | $ 215,000 | ||||||||
| Proceeds from warrant exercise | $ 45,000 | $ 22,000 | ||||||||
| Series A Preferred Stock [Member] | ||||||||||
| Number of shares issued | 5,030 | |||||||||
| Note Holder [Member] | ||||||||||
| Number of stock options granted | 25,272 | |||||||||
| Number of stock options granted, value | $ 182,000 | |||||||||
| Notes Payable [Member] | ||||||||||
| Number of common stock shares issued upon conversion | 780,619 | |||||||||
| Debt conversion amount | $ 1,129,000 | |||||||||
| Accounts Payable [Member] | ||||||||||
| Debt conversion amount | $ 10,000 | |||||||||
| Conversion of accounts payable into common stock shares | 4,142 | |||||||||
| Conversion of accounts payable into common stock | $ 10,000 | |||||||||
| Convertible Notes Payable [Member] | ||||||||||
| Warrant to purchase of common stock | 108,196 | 108,196 | ||||||||
| Warrant exercise price | $ 3.44 | $ 3.44 | ||||||||
| Warrant expiration date | Jul. 31, 2024 | Jul. 31, 2024 | ||||||||
| Fair value of warrants | $ 217,000 | $ 217,000 | ||||||||
| Vendor [Member] | ||||||||||
| Number of common stock shares issued for service | 354,288 | |||||||||
| Number of common stock shares issued for service, value | $ 930,000 | |||||||||
| Employees and Consultant [Member] | ||||||||||
| Number of stock options granted | 735,667 | |||||||||
| Exercise price of common stock granted | $ 3.97 | |||||||||
| Options expiration period, description | one or five years | |||||||||
| Options vesting percentage | 100.00% | |||||||||
| Stock option vesting period | The options have an average exercise price of $3.97 per share, expire in one or five years, and vests (i) 100% on the grant date, (ii) 50% on the grant date and the remaining 50% on the 12-month anniversary of the grant date, (iii) in three equal installments during the three years from the grant date, (iv) in 4 equal installments during the four years from the grant date, or (v) in 12 equal installments based on achieving performance targets during the three years from the grant date. | |||||||||
| Fair value of stock options grants | $ 2,155,000 | |||||||||
| Expense recognized relating to stock options | 1,505,000 | |||||||||
| Unrecognized stock based compensation expense | $ 4,300,000 | $ 4,300,000 | ||||||||
| Common Stock [Member] | ||||||||||
| Number of shares issued | 1,163,938 | |||||||||
| Number of shares issued for acquisition | 3,327,791 | 3,327,791 | ||||||||
| Value of shares issued for acquisition | $ 7,820,000 | |||||||||
| Number of common stock shares issued for service | 156,478 | 354,288 | 319,346 | |||||||
| Number of common stock shares issued for service, value | ||||||||||
| Number of common stock shares issued upon conversion | 750,988 | 1,243,189 | ||||||||
| Debt conversion amount | ||||||||||
| Series A Preferred Stock and Warrants [Member] | ||||||||||
| Proceeds from issuance of preferred shares and warrants | $ 4,688,000 | |||||||||
| Direct costs of issuance | 342,000 | |||||||||
| Warrant [Member] | ||||||||||
| Warrant to purchase of common stock | 163,739 | 163,739 | ||||||||
| Warrant exercise price | $ 3.76 | $ 3.76 | ||||||||
| Warrant expiration date | Apr. 30, 2024 | Apr. 30, 2024 | ||||||||
| Direct costs of issuance | 1,485,000 | |||||||||
| Derivative liability | 6,173,000 | |||||||||
| Reduction to additional paid in capital | $ 4,688,000 | |||||||||
| Stock options intrinsic value | $ 0 | $ 0 | ||||||||
| Fair value of warrants | $ 439,000 | $ 439,000 | ||||||||
| Number of warrants exercised | 186,969 | |||||||||
| Warrant [Member] | ||||||||||
| Warrant exercise price | $ 1.15 | $ 1.15 | ||||||||
| Conversion of accounts payable into common stock shares | 173,714 | |||||||||
| Proceeds from warrant exercise | $ 45,000 | |||||||||
| Public Offering [Member] | ||||||||||
| Proceeds from public offering | $ 18,524,000 | |||||||||
| Other offering expense | $ 2,138,000 | |||||||||
| Legal and professional expenses | $ 162,000 | |||||||||
| Public Offering [Member] | Underwriter Warrants [Member] | ||||||||||
| Warrant to purchase of common stock | 319,488 | |||||||||
| Warrant exercise price | $ 3.913 | |||||||||
| Public Offering [Member] | Common Stock [Member] | ||||||||||
| Warrant to purchase of common stock | 6,869,084 | 6,869,084 | ||||||||
| Warrant exercise price | $ 3.46 | $ 3.46 | ||||||||
| Warrant expiration date | Apr. 30, 2024 | Apr. 30, 2024 | ||||||||
| Preferred Stock Offering [Member] | ||||||||||
| Warrant to purchase of common stock | 3,245,162 | 3,245,162 | ||||||||
| Warrant exercise price | $ 1.88 | $ 1.88 | ||||||||
| Warrant expiration date | Aug. 31, 2024 | Aug. 31, 2024 | ||||||||
| Underwriting Agreement [Member] | ||||||||||
| Number of units issued under offering | 6,389,776 | |||||||||
| Number of shares issued | 6,389,776 | |||||||||
| Warrant to purchase of common stock | 6,389,776 | |||||||||
| Underwriting Agreement [Member] | Over-allotment Option [Member] | ||||||||||
| Number of units issued under offering | 159,820 | |||||||||
| Number of shares issued | 159,820 | |||||||||
| Warrant to purchase of common stock | 159,820 | |||||||||
| Underwriting Agreement [Member] | Alliance Global Partners [Member] | ||||||||||
| Number of units issued under offering | 6,389,776 | |||||||||
| Number of shares issued | 6,389,776 | |||||||||
| Warrant to purchase of common stock | 6,389,776 | |||||||||
| Shares issued price per share | $ 3.13 | |||||||||
| Underwriting Agreement [Member] | Alliance Global Partners [Member] | Option Shares [Member] | ||||||||||
| Number of units issued under offering | 958,466 | |||||||||
| Number of shares issued | 958,466 | |||||||||
| Warrant to purchase of common stock | 958,466 | |||||||||
| Warrant exercise price | $ 3.443 | |||||||||
| Warrant term | 5 years | |||||||||
| Warrant expiration date | Apr. 09, 2024 | |||||||||
| Securities Purchase Agreement [Member] | ||||||||||
| Number of shares issued | 5,030 | |||||||||
| Warrant to purchase of common stock | 3,870,000 | |||||||||
| Warrant exercise price | $ 1.88 | |||||||||
| Conversion of stock, number of shares issued | 3,870,000 | |||||||||
| Securities Purchase Agreement [Member] | Maximum [Member] | ||||||||||
| Warrant to purchase of common stock | 3,870,000 | |||||||||
| Number of share warrants granted to issue | 3,245,162 | |||||||||
| Securities Purchase Agreement [Member] | Series A Preferred Stock [Member] | ||||||||||
| Number of shares agreed to be issued | 6,000 | |||||||||
| Preferred stock conversion, description | Each share of Series A Preferred Stock is convertible, at any time and from time to time from and after the issuance date, at the holder’s option in to that number of shares of Common Stock equal to the stated value per share (or $1,000) divided by the conversion price (initially, $1.55); thus, initially, each share of Series A Preferred Stock is convertible into approximately 645 shares of Common Stock. In certain circumstances, the Series A Preferred Stock is mandatorily convertible into shares of Common Stock after the Company obtains stockholder approval to issue a number of shares of Common Stock in excess of 19.99% and the closing price of the Common Stock is 100% greater than the then-base conversion price on each trading day for any 20 trading days during a consecutive 30-trading-day period. The holders of Series A Preferred Stock cannot convert the Series A Preferred Stock if, after giving effect to the conversion, the number of shares of our Common Stock beneficially held by the holder (together with such holder’s affiliates) would be in excess of 4.99% (or, upon election by a holder prior to the issuance of any shares, 9.99% of the number of shares of Common Stock issued and outstanding immediately after giving effect to the issuance of any shares of Common Stock issuance upon conversion of the Series A Preferred Stock held by the holder). The conversion price of the Series A Preferred Stock is subject to certain customary adjustments, including upon certain subsequent equity sales and rights offerings. | |||||||||
| Securities Purchase Agreement [Member] | Series A Preferred Stock and Warrants [Member] | ||||||||||
| At-the-market agreement terms, description | We are also prohibited, until the date that the Preferred Purchasers no longer collectively hold at least 20% of the then-outstanding shares of Series A Preferred Stock issued pursuant to the SPA, from entering into an agreement to effect any issuance by us of Common Stock or Common Stock equivalents involving certain variable rate transactions. We also cannot enter into agreements related to “at-the-market” transactions for a period of 12 months. At the later of (i) the date that the Warrants are fully exercised, and (ii) 12 months from the date of the SPA, we cannot draw down on any existing or future agreement with respect to “at-the-market” transactions if the sale of the shares in such transactions has a per share purchase price that is less than $3.76 (two times the exercise price of the Warrants). | |||||||||
| Preferred stock conversion, description | Each share of Series A Preferred Stock is convertible, at any time and from time to time from and after the issuance date, at the holder’s option in to that number of shares of Common Stock equal to the stated value per share (or $1,000) divided by the conversion price (initially, $1.55); thus, initially, each share of Series A Preferred Stock is convertible into approximately 645 shares of Common Stock. In certain circumstances, the Series A Preferred Stock is mandatorily convertible into shares of Common Stock after the Company obtains stockholder approval to issue a number of shares of Common Stock in excess of 19.99% and the closing price of the Common Stock is 100% greater than the then-base conversion price on each trading day for any 20 trading days during a consecutive 30-trading-day period. The holders of Series A Preferred Stock cannot convert the Series A Preferred Stock if, after giving effect to the conversion, the number of shares of our Common Stock beneficially held by the holder (together with such holder’s affiliates) would be in excess of 4.99% (or, upon election by a holder prior to the issuance of any shares, 9.99% of the number of shares of Common Stock issued and outstanding immediately after giving effect to the issuance of any shares of Common Stock issuance upon conversion of the Series A Preferred Stock held by the holder). The conversion price of the Series A Preferred Stock is subject to certain customary adjustments, including upon certain subsequent equity sales and rights offerings. | |||||||||
| Conversion price per share | $ 1.55 | |||||||||
| Shareholders' approval percentage for mandatory conversion | 19.99% | |||||||||
| Number of common stock to be issued causing ineligibility to issue common stock | 4,459,725 | |||||||||